Nanobiotix S.A. (NBTX)

Nanobiotix Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 18, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	1,059	148	346	135	289	581
Market Cap Growth	565.97%	-57.08%	156.46%	-53.41%	-50.20%	179.88%
Enterprise Value	1,085	131	382	116	231	612
Last Close Price	22.10	2.87	7.28	3.67	8.10	16.50
PS Ratio	88.74	-19.94	8.64	26.42	96.13	204.34
PB Ratio	-	-2.18	-169.73	-4.66	9.50	6.74
P/TBV Ratio	-	-	-	-	9.50	6.74
EV/Sales Ratio	90.95	-	9.53	22.66	76.63	215.20
Debt / Equity Ratio	-0.74	-0.77	-27.44	-1.97	1.72	0.70
Asset Turnover	0.15	-	0.47	0.06	0.02	0.02
Quick Ratio	0.58	0.98	1.68	1.23	2.38	6.42
Current Ratio	0.63	1.04	1.75	1.38	2.53	6.58
Return on Equity (ROE)	-	-	-	-	-96.66%	-97.99%
Return on Assets (ROA)	-41.64%	-52.89%	-19.72%	-35.38%	-25.00%	-24.06%
Return on Capital (ROIC)	-567.29%	-251.54%	-40.48%	-57.76%	-30.66%	-28.24%
Return on Capital Employed (ROCE)	245.90%	-804.60%	-55.10%	-209.40%	-72.60%	-31.80%
Earnings Yield	-5.73%	-47.53%	-12.69%	-45.21%	-18.47%	-7.07%
FCF Yield	-3.50%	-14.23%	-4.09%	-29.48%	-11.83%	-5.82%
Buyback Yield / Dilution	-10.33%	-27.99%	-5.96%	-0.34%	-42.43%	-12.73%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q